Safranal improves the anticancer efficacy of sorafenib via transcriptomic reprogramming and metabolomic changes in a rat model of diethylnitrosamine-induced cirrhosis–hepatocellular carcinoma

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher
Authors: Ameera Al Mansoori, Badriya Baig, Rania Harati, Reem Sami Alhamidi, Alaaeldin A. Hamza, S Al-Salam, Anne Le, Cissy Zhang, Pratik Khare, Rifat Hamoudi, Amr Amin
DOI: 10.1007/s00210-026-05573-6
Cited by: 6
References: 62

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Liver physiology and pathology Saffron Plant Research Studies

Publication details

Journal / source
Naunyn-Schmiedeberg s Archives of Pharmacology
Publisher
Springer Science and Business Media LLC
Volume
399
Issue
12
Pages
19597-19616
Publication date
26 June 2026
Language
EN